iSpecimen Inc .

Prior to launching iSpecimen, Chris served as Managing Director at Leerink Partners (formerly Leerink Swann), a leading healthcare and life science investment bank, where he managed the expansion and delivery of services and directed strategy to develop new healthcare data and information assets for the firm. Talk with your doctor and family members or friends about deciding to join a study. Get the full list », You’re viewing 5 of 14 executive team members.

He then worked on clinical trials at Wyeth that led to the development of Xyntha®, a drug used to treat hemophilia. Tracy received her Master of Accountancy and Bachelor of Science in Business Administration with a concentration in accounting from Kansas State University.

Eric has amassed nearly 20 years of experience in the arena of preclinical sample collections and biobanking for translational research.

Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut. At Leerink, Chris launched Health Insight Technologies, a healthcare informatics company that was spun out of the firm as Humedica and acquired by UnitedHealth Group in 2013. A: I am healthy, strong, and excited about the future.

Individual Participant Data (IPD) Sharing Statement: Studies a U.S. FDA-regulated Drug Product: Studies a U.S. FDA-regulated Device Product: Distribution of Biospecimens From Biorepositories/Biobanks for Research Use [ Time Frame: 15 years ]. I’ve now served as a research subject in several different types of studies.

Q: Can you tell us a little about the studies in which you have participated? It was for the University of Texas, they were looking for women with a past diagnosis of breast cancer. She was also the Director of Product Marketing and Management at Avid Technology, managing the P&L for Avid’s $400M editing product line. David began his career working on the clinical development of novel drug-device combinations for blood decontamination at Cerus Corporation. Jill is responsible for ensuring operational excellence throughout the company. Nam aliquando posse. Name: Jill Mullan. While iSpecimen serves the research community every day through our professional endeavors, the advancement of medicine is also deeply personal to us. You can join for free and creating a login is easy. Why have you chosen a career in biotech, and why iSpecimen? Ispecimen Inc. is a Massachusetts Foreign Corporation filed on September 12, ... Christopher Ianelli from Lexington MA, George Scholl from Lexington MA, Jill Mullan from Lexington MA, and Joseph Ianelli from Lexington MA.

Organization: iSpecimen. "publisher": {

The company's marketp, cididunt ut labore et dolore magna aliqua. Information provided by (Responsible Party): This protocol seeks to assist biorepositories/biobanks in distributing their stored specimens and data to researchers that will actually utilize them to advance medicine and technology. Ut enim ad minim veniam, quis nostrud exercitation ullamc, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Jill is an exceptional marketing professional with broad strengths in strategic thinking, tactical execution and analysis.

"@id": "https://www.ispecimen.com/blog/five-questions-with-jill-mullan/" Investigators.

A: A year and a half ago, I was diagnosed with breast cancer. He will help shape future capabilities of the iSpecimen Marketplace.

Request a quote or custom collection today. "mainEntityOfPage": { She moved quickly from the lab into management of Technical and Customer Support and Sales for companies such as Research Genetics, Invitrogen/Life Technologies and Thermo Fisher Scientific. Jill Mullan, our Chief Operating Officer, volunteers as a research subject for medical studies. Why have you chosen a career in biotech, and why iSpecimen? When Chris called me to talk about his idea for starting iSpecimen, I was immediately hooked. The safety and scientific validity of this study is the responsibility of the study sponsor and investigators.


Get the full list », To view iSpecimen’s complete board members history, request access », To view iSpecimen’s complete investors history, request access », Chief Executive Officer, Board Member & Founder. document.write(new Date().getFullYear()); Bud is a graduate of the University of Florida and holds an engineering degree in computer science. iSpecimen Marketplace for Health Information Exchanges.

To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. Q: Would you say this is an exciting time for treatment research?

Prior to joining iSpecimen, Wayne served as Vice President, Corporate & Business Development with AllCells, LLC.


Madhu led cross-functional software engineering teams at GNS Healthcare, Optum, Medtronic, GMO, BNY Mellon, and successfully delivered commercial and enterprise platforms using web, desktop, cloud, bigdata, NoSQL, machine learning, and data management technologies. Provider of human biospecimens marketplace intended to help medical researchers to discover drugs. Ut enim ad minim veniam, quis no, To view iSpecimen’s complete valuation and funding history, request access », To view iSpecimen’s complete cap table history, request access », You’re viewing 5 of 8 competitors.